HQ: Budapest, Hungary
Countries we work from: Hungary, United Kingdom, Spain, The Netherlands, United States of America, Italy, Poland, Belgium, Austria, Germany
Team size: 80+
Founders: Nagy Szabolcs (CEO), Dr. Veres Dániel (CSO), Szalay Kristóf (CTO), Dr. Fekete Iván (Lead Application Scientist)
Founding date: 2016
Notable investors: Accel, Mercia Asset Management, XTX Ventures, Delin Ventures, Interactive Venture Partners, MassMutual Ventures, MSD Global Health and Innovation Fund, Accenture and others
Investment Stage: Series B
Funding to date: $60M+
A lab without limits, built for biopharma. Turbine’s Virtual Lab is a proven platform for simulating biology way past traditional R&D scale. Our partners use it to run millions of virtual experiments, prioritize the wet lab work that matters, and build stronger preclinical decision packages faster. We don’t replace the wet lab. We make every experiment count. Working with scientists at leading biopharma like MSD (Merck & Co.), AstraZeneca and Bayer, our Virtual Assays have rationalized experiments across more than 30 discovery programs. Backed by leading tech and industry investors like Accel, MSD Global Health Innovation Fund, Interactive Venture Partners and Beiersdorf, we are turning biology into an engineering discipline.
Please use these assets as provided or follow the included brand guidelines for any adaptations.
If you have any questions for our communications team, or would like to request an interview, data, or comment, contact us here.